ArticleCancer chemotherapy and pharmacology2016

Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.

Takaya Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.